Australia's Lumos Diagnostics eyes best week in 14 on product expansion
Yesterday 03:04
BUZZ-Australia's Lumos Diagnostics eyes best week in 14 on product expansion ** Shares of Australia's Lumos Diagnostics LDX.AX fall 1.4% to A$0.07
** However, stock rises 16.7% so far in the week, headed for their best week since August 3, if gains hold
** Diagnostics test technology firm on Monday said US-based WellStreet Urgent Care would expand adoption of its FebriDx respiratory infection test to an additional 97 locations across the United States
** Stock down 75.4% YTD, including moves in current session
(Reporting by Swetha Lakshmi in Bengaluru)
Recent news on Lumos Diagnostics Holdings
See all newsAustralia's Lumos Diagnostics eyes best week in 14 on product expansion
Australia's Lumos Diagnostics rises on product expansion by US care network
Australia's Lumos Diagnostics hits over 1-year low on quarterly revenue slump
Brief: Lumos Diagnostics Posts Q1 FY27 Revenue Of US$2.0 Million
Brief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million